PAD 0106 (Bromocriptine 2.5 mg)
Pill imprint PAD 0106 has been identified as Bromocriptine mesylate 2.5 mg.
Bromocriptine is used in the treatment of parkinson's disease; diabetes, type 2; acromegaly; tardive dyskinesia; hyperprolactinemia and belongs to the drug classes dopaminergic antiparkinsonism agents, prolactin inhibitors. There is no proven risk in humans during pregnancy. Bromocriptine 2.5 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for PAD 0106 (Bromocriptine 2.5 mg)
- Imprint:
-
PAD 0106
- Strength:
- 2.5 mg
- Color:
- White
- Size:
- 8.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Dopaminergic antiparkinsonism agents
Prolactin inhibitors - Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Paddock Laboratories, Inc.
- National Drug Code (NDC):
- 00574-0106
- Inactive Ingredients:
- lactose anhydrous
silicon dioxide
magnesium stearate
maleic acid
povidone
More resources
Bromocriptine mesylate is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
